Skip to main content

Polyarteritis Nodosa

  • Chapter
  • First Online:
Systemic Vasculitides: Current Status and Perspectives

Abstract

Polyarteritis nodosa (PAN) is a rare vasculitis affecting middle-sized arteries. Its annual incidence in Europe is estimated to range between 0 and 1.6 cases per million, while the prevalence is about 31 cases per million. The frequency of hepatitis B virus (HBV)-related PAN has declined in developed countries since vaccination against HBV has been implemented. Specifically, before vaccination against HBV was implemented on a large scale, more than one-third of adults with PAN were infected by HBV, whereas currently only 5 % of European adults with PAN are infected by HBV. PAN is usually considered an immune-complex-driven vasculitis. However, the evidence of abundant CD4+ T cells in vascular inflammatory infiltrates suggests that PAN may also be induced by a T-cell response. Clinically, PAN usually presents with constitutional manifestations as well as symptoms and signs related to the organs affected. Organ ischemia is thought to be due to vascular stenoses, while ruptured aneurysms can result in tissue hemorrhage. The most frequent clinical features include constitutional manifestations, myalgia, arthralgia, peripheral neuropathy and mononeuritis multiplex. There are no specific blood tests to diagnose PAN, but inflammatory markers are typically elevated. Therefore, the diagnosis rests on histological changes in affected organs, showing a transmural vessel wall infiltrate, or angiographic findings, including small saccular or fusiform aneurysms and stenoses. Treatment includes glucocorticoids in patients without poor prognostic factors or cyclophosphamide if the disease is life- or organ-threatening.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kußmaul A, Maier R (1886) Über eine bisher nicht beschriebene eigenthümliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Dtsch Arch Klin Med 1:484–516

    Google Scholar 

  2. Ferrari E (1903) Über polyarteritis acuta nodosa (sogenannte Periarteritis nodosa) und ihre Beziehungen zur Polymyositis and Polyneuritis acuta. Beitr Pathol Anat 34:350–386

    Google Scholar 

  3. Dickson WEC (1908) Polyarteritis acuta nodosa and periarteritis nodosa. J Pathol 12:31–47

    Article  Google Scholar 

  4. Wainwright J, Davson J (1950) The renal appearances in the microscopic form of periarteritis nodosa. J Pathol 62:189–196

    Article  CAS  Google Scholar 

  5. Wohlwill F (1923) Über die nur mikroskopisch erkennbare Form der Periarteritis nodosa. Virchows Arch 246:377–411

    Article  Google Scholar 

  6. Lightfoot RW Jr, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33:1088–1093

    Article  PubMed  Google Scholar 

  7. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187–192

    Article  CAS  PubMed  Google Scholar 

  8. Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11

    Article  CAS  PubMed  Google Scholar 

  9. Watts R, Lane S, Hanslik T et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227

    Article  PubMed  Google Scholar 

  10. Ozen S, Pistorio A, Iusan SM et al (2010) EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798–806

    Article  PubMed  Google Scholar 

  11. Flores-Suarez LF, Contreras-Rodriguez FJ (2014) Critical appraisal of classification criteria for vasculitides. Curr Rheumatol Rep 16:422

    Article  PubMed  Google Scholar 

  12. Ishiguro N, Kawashima M (2010) Cutaneous polyarteritis nodosa: a report of 16 cases with clinical and histopathological analysis and a review of the published work. J Dermatol 37:85–93

    Article  PubMed  Google Scholar 

  13. Nakamura T, Kanazawa N, Ikeda T et al (2009) Cutaneous polyarteritis nodosa: revisiting its definition and diagnostic criteria. Arch Dermatol Res 301:117–121

    Article  PubMed  Google Scholar 

  14. Nakamura T, Tomoda K, Yamamura Y, Tsukano M, Honda I, Iyama K (2003) Polyarteritis nodosa limited to calf muscles: a case report and review of the literature. Clin Rheumatol 22:149–153

    Article  PubMed  Google Scholar 

  15. Dotan ZA, Laufer M, Heldenberg E et al (2003) Isolated testicular polyarteritis nodosa mimicking testicular neoplasm-long-term follow-up. Urology 62:352

    Article  PubMed  Google Scholar 

  16. Ebert EC, Hagspiel KD, Nagar M, Schlesinger N (2008) Gastrointestinal involvement in polyarteritis nodosa. Clin Gastroenterol Hepatol 6:960–966

    Article  PubMed  Google Scholar 

  17. Mahr A, Guillevin L, Poissonnet M, Ayme S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51:92–99

    Article  PubMed  Google Scholar 

  18. Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337

    Article  CAS  Google Scholar 

  19. Pagnoux C, Cohen P, Guillevin L (2006) Vasculitides secondary to infections. Clin Exp Rheumatol 24:S71–S81

    CAS  PubMed  Google Scholar 

  20. Pipitone N, Salvarani C (2008) The role of infectious agents in the pathogenesis of vasculitis. Best Pract Res Clin Rheumatol 22:897–911

    Article  CAS  PubMed  Google Scholar 

  21. Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, Cid MC (2014) Diagnosis and classification of polyarteritis nodosa. J Autoimmun 48–49:84–89

    Google Scholar 

  22. Pagnoux C, Seror R, Henegar C et al (2010) Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62:616–626

    Article  PubMed  Google Scholar 

  23. Bonsib SM (2001) Polyarteritis nodosa. Semin Diagn Pathol 18:14–23

    CAS  PubMed  Google Scholar 

  24. Pagnoux C, Mahr A, Cohen P, Guillevin L (2005) Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) 84:115–128

    Article  Google Scholar 

  25. Guillevin L, Lhote F, Gayraud M et al (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75:17–28

    Article  CAS  Google Scholar 

  26. Ribi C, Cohen P, Pagnoux C et al (2010) Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum 62:1186–1197

    Article  PubMed  Google Scholar 

  27. Guillevin L, Cohen P, Mahr A et al (2003) Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum 49:93–100

    Article  CAS  PubMed  Google Scholar 

  28. Langford CA (2001) Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: where do we stand? Arthritis Rheum 44:508–512

    Article  CAS  PubMed  Google Scholar 

  29. de MM, Mahr A (2011) Treating polyarteritis nodosa: current state of the art. Clin Exp Rheumatol 29:S110–S116

    Google Scholar 

  30. Guillevin L, Mahr A, Cohen P et al (2004) Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 51:482–487

    Article  CAS  PubMed  Google Scholar 

  31. Guillevin L, Mahr A, Callard P et al (2005) Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84:313–322

    Article  Google Scholar 

  32. Segelmark M, Selga D (2007) The challenge of managing patients with polyarteritis nodosa. Curr Opin Rheumatol 19:33–38

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carlo Salvarani .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pipitone, N., Salvarani, C. (2016). Polyarteritis Nodosa. In: Dammacco, F., Ribatti, D., Vacca, A. (eds) Systemic Vasculitides: Current Status and Perspectives. Springer, Cham. https://doi.org/10.1007/978-3-319-40136-2_16

Download citation

Publish with us

Policies and ethics